About Advenza Global Limited
Advenza Global Limited is a Public Limited Company and was incorporated on Feb 17, 2005 in India. It is registered at Registrar of Companies, ROC Mumbai II. Its registered address is Lodha Supremus II, Unit No.: 424, 4th F Road No. 22, Wagle Estate, Thane West, Maharashtra, India, 400604. Its corporate identification number is (CIN) U24230MH2005PLC151389 and its current status is Active. It has 4 GST numbers registered across 3 states. These include 24AAFCA1050L1Z0 in Gujarat (active) and 02AAFCA1050L1Z6 in Himachal Pradesh (active). As of Oct, 2026, all 4 GST numbers are active. Its industry classification as per MCA is manufacture Of Pharmaceuticals, Medicinal Chemicals And Botanical Products. It had a team size of 209 employees as on Apr 01, 2026.
Advenza Global Limited's last Annual General Meeting (AGM) was held on Sep 30, 2025 as per records from Ministry of Corporate Affairs (MCA). Advenza Global Limited's authorised share capital is ₹261Cr and its paid up capital is ₹259Cr. The current board of directors of Advenza Global Limited comprises Piyush Chandrakumar Rathi, Savita Chandrakumar Rathi and 5 more.
Advenza Global Limited generated between ₹50 Cr and ₹100 Cr in revenue for the financial year ending on Mar 31, 2025.
Contact Details for Advenza Global Limited
- *****@advenza.co.in, *****@lotusbloom.in
- Registered Address
- Lodha Supremus II, Unit No.: 424, 4th F Road No. 22, Wagle Estate, Thane West, Maharashtra, India, 400604
Brands associated with Advenza Global Limited
Name | Short Description | Founded Year | Location | Current Stage |
|---|---|---|---|---|
Manufacturer of enzymes for human nutrition, animal nutrition, food processing, and industrial applications | 1989 | Public | ||
Manufacturer of enzyme and custom probiotics solutions | 2005 | Unfunded |
Principal Business Activity of Advenza Global Limited
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
C | Manufacturing | 20 | Manufacture of chemicals and chemical products | k{e |
Auditor Details of Advenza Global Limited
Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
S LAKHOTIA & ASSOCIATES | aivhmud | yfx{zpf | wjpxegn |
Documents of Advenza Global LimitedFY 25 Available15 mins
Filing Summary
Here is a summary of filing activity and document availability across financial years:
File Type | FY 24-25 | FY 23-24 | FY 22-23 | FY 21-22 | FY 20-21 |
|---|---|---|---|---|---|
Financial Statements | |||||
Annual Returns |
Latest Financials, Share Allotment and Annual Report
The latest filed financial documents, annual reports, and share allotment filings are shown below:
Recent Filings
Below are the most recent filings submitted by the company:
Document Name | Category | Filing Date |
|---|---|---|
Form MSME | Other eForm Documents | Apr 24, 2026 |
Copy(s) of resolution(s) along with copy of explanatory statement under section 173 | Other eForm Documents | Feb 16, 2026 |
Form MGT-14 | Other eForm Documents | Feb 16, 2026 |
Optional attachment(s)- if any | Annual Returns and Balance Sheet eForms | Jan 30, 2026 |
List of share holders, debenture holders; | Annual Returns and Balance Sheet eForms | Jan 30, 2026 |
Form MGT-7 | Annual Returns and Balance Sheet eForms | Jan 30, 2026 |
Form AOC-4(XBRL) | Annual Returns and Balance Sheet eForms | Jan 30, 2026 |
Form CSR-2 | Annual Returns and Balance Sheet eForms | Jan 30, 2026 |
Photograph of the registered office of the Company showing external building and name prominently visible | Annual Returns and Balance Sheet eForms | Jan 30, 2026 |
Form MSME | Other eForm Documents | Oct 29, 2025 |
Financials of Advenza Global LimitedFY 25 Available15 mins
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 2681 | 8895 | 1340 | 2105 | 6907 |
Total Sales | 2773 | 2276 | 1361 | 6807 | 3991 |
Total Expenses | 3547 | 6502 | 8237 | 5592 | 5080 |
Operating Expenses | 2093 | 4373 | 3551 | 7282 | 9872 |
Employee Expenses | 4278 | 5346 | 9764 | 1827 | 6469 |
Marketing Expenses | 5610 | 1915 | 3669 | 5922 | 1958 |
Operating Income (EBIT) | 1315 | 3526 | 5436 | 7456 | 7150 |
Interest Expenses | 4298 | 7394 | 5462 | 7622 | 2899 |
Expenses from other activities | 8825 | 9926 | 3426 | 9332 | 1757 |
Information Technology Expenses | 3522 | 9152 | 3633 | 6236 | 4025 |
EBITDA | 3682 | 5479 | 1005 | 2278 | 3108 |
Taxes | 6668 | 9821 | 3912 | 9402 | 7714 |
Net Profit | 7432 | 4949 | 6117 | 5553 | 4230 |
Balance Sheet | |||||
Assets | 4730 | 6145 | 9715 | 9653 | 7627 |
Cash Equivalent | 1152 | 3685 | 8567 | 6179 | 7318 |
Accounts Receivables | 5804 | 5041 | 6539 | 3029 | 8087 |
Inventory | 3168 | 1376 | 2465 | 6086 | 1830 |
Liabilities | 6730 | 2402 | 2601 | 5235 | 5800 |
Total Debt | 4617 | 2217 | 3956 | 6257 | 9052 |
Accounts Payable | 4900 | 9788 | 3632 | 2447 | 9151 |
Equities | 5379 | 7413 | 9601 | 9229 | 3858 |
Cashflow Statement | |||||
Cash from Operating activities | 4035 | 4235 | 3453 | 9295 | 7503 |
Cash from Investing activities | 9712 | 5165 | 8561 | 4863 | 9792 |
Net cash from Financing activities | 1898 | 6805 | 5655 | 4209 | 3696 |
Ratios
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Profitability Ratios | |||||
EBITDA Margin | 4235 | 5471 | 7335 | 8379 | 5420 |
EBIT Margin | 5763 | 7218 | 8007 | 8479 | 4295 |
Net Profit Margin | 9258 | 9493 | 6816 | 9044 | 9936 |
Return on Assets (ROA) | 4258 | 3566 | 3615 | 5163 | 7643 |
Return on Equity (ROE) | 7290 | 3597 | 7586 | 4463 | 5053 |
Return on Capital Employed | 5906 | 8243 | 7562 | 2517 | 1771 |
Return on Invested Capital | 7568 | 5041 | 5568 | 2186 | 4545 |
Efficiency Ratios | |||||
Asset Turnover | 4727 | 2713 | 9015 | 7383 | 5136 |
Receivables Turnover | 2239 | 6281 | 4120 | 7169 | 9633 |
Days Sales Outstanding | 6479 | 9379 | 7921 | 5536 | 4366 |
Inventory Turnover | 3084 | 5617 | 6302 | 8912 | 7129 |
Days Inventory Outstanding | 8238 | 4640 | 7817 | 4958 | 5805 |
Payables Turnover | 4875 | 5829 | 6655 | 2868 | 4520 |
Days Payables Outstanding | 1126 | 1318 | 3789 | 4552 | 6877 |
Liquidity Ratios | |||||
Current Ratio | 1865 | 8512 | 2455 | 2283 | 6492 |
Quick Ratio | 9891 | 9576 | 7238 | 5679 | 8247 |
Cash Ratio | 4754 | 5270 | 1101 | 3471 | 2662 |
Coverage Ratios | |||||
Cash Flow Coverage Ratio | 3361 | 7846 | 1520 | 4045 | 2194 |
Debt Ratios | |||||
Debt-to-Equity Ratio | 1392 | 3509 | 3232 | 7913 | 4389 |
Debt Ratio | 7107 | 5270 | 1944 | 9180 | 2808 |
Net Debt | 2291 | 6594 | 6311 | 4777 | 5060 |
Interest Coverage Ratio | 7482 | 9293 | 3445 | 8555 | 2642 |
Debt Service Coverage Ratio | 9692 | 7775 | 5835 | 6935 | 1279 |
Net Debt/EBITDA | 6296 | 1092 | 6190 | 1166 | 6963 |
Growth Ratios | |||||
Revenue Growth Rate (CAGR) | 1849 | 3170 | 4369 | 9266 | 3623 |
Earnings Growth Rate (CAGR) | 2255 | 1253 | 9782 | 5653 | 3379 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of Advenza Global Limited
Revenue CAGR | Growth |
|---|---|
1 Year | -57% |
3 Year | 242 |
5 Year | 477 |
EBITDA CAGR | Growth |
|---|---|
1 Year | -98% |
3 Year | 243 |
5 Year | 755 |
MSME Payment Delays by Advenza Global Limited
Supplier Name | Supplier PAN | Amount Due | Due since |
|---|---|---|---|
Saroj Art
Printers
Private
Limited | 1345 | 5182 | 8483 |
V.N.Pharma | 1646 | 5306 | 4448 |
Bharat Milling Industries | 3619 | 8371 | 1789 |
RADHEKRISHNA DISTRIBUTORS | 4868 | 4405 | 3879 |
Loans and Charges on Advenza Global Limited
As a Borrower
Loan/ Charge ID | Lender Name | Loan Amount | Status | Creation Date | Closure Date |
|---|---|---|---|---|---|
100240011 | ₹3.75Cr | zvxjqcg | Jan 30, 2019 | nydrvjq | |
10599909 | ₹1Cr | wvlnyxo | Oct 28, 2015 | vwpdgcx | |
10604386 | ₹1Cr | klofjli | Oct 15, 2015 | xjiyuyg |
GSTIN Details of Advenza Global Limited
Board of Directors and Signatories of Advenza Global Limited
Board of Directors of Advenza Global Limited
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Managing Director | Current | Dec 01, 2020 | 5 Years 10 Months | |
Director | Current | Feb 17, 2005 | 21 Years 7 Months | |
Director | Current | Feb 17, 2005 | 21 Years 7 Months | |
Director | Current | Sep 14, 2015 | 11 Years | |
Director | Current | Sep 14, 2015 | 11 Years | |
Director | Current | Aug 20, 2025 | 1 Year 1 Month | |
Director | Current | Aug 20, 2025 | 1 Year 1 Month |
Signatories of Advenza Global Limited
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Feb 17, 2005 | 21 Years 7 Months | |
Director | Current | Feb 17, 2005 | 21 Years 7 Months | |
Director | Current | Sep 14, 2015 | 11 Years | |
Director | Current | Sep 14, 2015 | 11 Years | |
Managing Director | Current | Dec 01, 2020 | 5 Years 10 Months | |
Company Secretary | Current | Jul 07, 2025 | 1 Year 3 Months | |
Director | Current | Aug 20, 2025 | 1 Year 1 Month | |
CFO | Current | Aug 20, 2025 | 1 Year 1 Month | |
Director | Current | Aug 20, 2025 | 1 Year 1 Month |
Cross Directorships of Advenza Global Limited
Legal Entity Name | % of Common Directors | Common Director(s) | Open Charge(s) | Active Legal Case(s) |
|---|---|---|---|---|
Shirdi Sai Nutraceuticals Private Limited CIN: U15139MH2012PTC450211, India, Active | 153 | 218 | 639 | 381 |
ATHARVA GREEN ECOTECH PRIVATE LIMITED CIN: U74110MH1993PTC073191, India, Converted to LLP | 933 | 261 | 335 | 991 |
CHANDRAKANT RATHI INNOVATIONS & PROJECTS PRIVATE LIMITED CIN: U74110MH1994PTC081231, India, Amalgamated | 157 | 768 | 669 | 333 |
Funding and Investors of Advenza Global Limited
Advanced Enzymes, the brand associated with Advenza Global Limited, has raised funding over 2 rounds. Its first funding round was on May 07, 2018. Its latest funding round was a Post IPO round on Sep 2020 for $*****. 1 investor participated in its latest round. Advanced Enzymes has 3 institutional investors.
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 2020 | 7328531 | Post IPO | 7270720 | 7788823 | 9608252 | 9058621 |
May 07, 2018 | 8002348 | Conventional Debt | 5660753 | 9068600 | 2595849 |
Legal Cases involving Advenza Global Limited
Employee Count of Advenza Global Limited
Date | Employee Count |
|---|---|
Apr 26 | 209 |
Mar 26 | 191 |
Feb 26 | 529 |
Jan 26 | 516 |
Dec 25 | 431 |
Nov 25 | 887 |
Oct 25 | 865 |
Competitors & Alternates of Advenza Global Limited
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of biosolutions and enzymes for multiple industries and applications of biotechnology | $9.75M | 73/100 | ||
2nd | Advanced Enzymes 1989, Thane (India), Public | Manufacturer of enzymes for human nutrition, animal nutrition, food processing, and industrial applications | - | 62/100 | |
3rd | Infinita Biotech 2015, Vadodara (India), Unfunded | Provider of enzymatic solutions for various industries | - | - | 40/100 |
4th | Manufacturer of enzyme and custom probiotics solutions | - | - | 39/100 | |
5th | Amlan International 1941, Chicago (United States), Unfunded | Provider of mineral-based feed additives that support animal intestinal health | - | - | 38/100 |
6th | Antozyme Biotech 2015, Vadodara (India), Unfunded | Enzymes manufacturing and formulation company | - | - | 37/100 |
7th | Provider of dolomite, clay products, and nutritional supplements for animal feed | - | - | 36/100 | |
8th | Manufacturer of tissue engineered products and enzymes for multiple industries | - | 34/100 | ||
9th | Tex Biosciences 1979, Chennai (India), Funding Raised | Manufacturer of enzymes, probiotics, and specialty chemicals for various industries | - | 32/100 | |
10th | Company specializing in the development and manufacturing of enzymes for various industries, including food, baking, animal feed, and pharmaceuticals | - | - | 32/100 |
